Published in Arch Ophthalmol on November 01, 1970
Normal response to pilocarpine and phenylephrine. Br J Ophthalmol (1977) 2.66
Piloplex, a new long-acting pilocarpine polymer salt. A: Long-term study. Br J Ophthalmol (1979) 0.75
Flux of topical pilocarpine to the human aqueous. Trans Am Ophthalmol Soc (1978) 0.75
Topical drug therapy in glaucoma. Wien Med Wochenschr (2006) 0.75
The effect of various neurohumoral modulators on the activity of morphine and the narcotic antagonists in the tail-flick and phenylquinone tests. J Pharmacol Exp Ther (1970) 2.01
Determination and characterization of the antinociceptive activity of intraventricularly administered acetylcholine in mice. J Pharmacol Exp Ther (1975) 1.52
Paclitaxel, carboplatin, and hexamethyl-melamine (taxchex) as first-line therapy for ovarian cancer. Cancer J Sci Am (1999) 1.39
Out-patient cataract surgery. Trans Ophthalmol Soc U K (1975) 1.38
Sudden death associated with aortitis and fibrosclerosing disease of the conduction system. Arch Pathol Lab Med (1992) 1.38
Suction ophthalmodynamometry via fluidic control. Trans Am Acad Ophthalmol Otolaryngol (1971) 1.37
Fluorescein angiography during induced ocular hypertension in man. Am J Ophthalmol (1970) 1.33
Ocular circulation: analysis of the effect of induced ocular hypertension on reginal and choroidal blood flow in man. Am J Ophthalmol (1971) 1.32
Growth of Toxoplasma gondii in various tissue cultures treated with In-Cn or interferon. Proc Soc Exp Biol Med (1973) 1.26
Effect of osmotic agents on the vitreous body. Arch Ophthalmol (1969) 1.23
Narcotic-antagonist analgesics: interactions with cholinergic systems. J Pharmacol Exp Ther (1969) 1.17
Inhibition of writhing by narcotic antagonists. J Pharmacol Exp Ther (1966) 1.16
Respiratory difficulties with betaxolol. Am J Ophthalmol (1986) 1.15
Conjunctival and corneal calcific deposits in uremic patients. Am J Ophthalmol (1971) 1.14
Antineoplastic activity of cannabinoids. J Natl Cancer Inst (1975) 1.14
Cycloplegic-induced intraocular pressure elevations a study of normal and open-angle glaucomatous eyes. Arch Ophthalmol (1968) 1.12
Optically pure (+)-nicotine from (+/-)-nicotine and biological comparisons with (-)-nicotine. J Med Chem (1979) 1.12
Pharmacology of some marijuana constituents and 2 heterocyclic analogues. Nature (1970) 1.11
Nonsurgical removal of corneal rust stains. Arch Ophthalmol (1965) 1.10
Reduction of vitreous weight by ocular massage. Am J Ophthalmol (1970) 1.10
Cerebro-vascular insufficiency. Trans Am Acad Ophthalmol Otolaryngol (1967) 1.09
Effect of ocular pigmentation on hypotensive response to pilocarpine. Am J Ophthalmol (1971) 1.08
Central neurohumoral systems involved with narcotic agonists and antagonists. Fed Proc (1970) 1.08
Drugs derived from cannabinoids. 1. Nitrogen analogs, benzopyranopyridines and benzopyranopyrroles. J Med Chem (1976) 1.07
Ocular pulse studies in carotid stenosis. Relationship to carotid hemodynamics. Arch Ophthalmol (1971) 1.06
Critical closure of intraocular blood vessels. Arch Ophthalmol (1969) 1.05
Radiation therapy of choroidal melanoma. Trans Ophthalmol Soc U K (1977) 1.04
Trimolol: effect on intraocular pressure in chronic open-angle glaucoma. Ann Ophthalmol (1978) 1.03
Evidence for the existence of specific cannabinoid binding sites. Life Sci (1978) 1.03
Dependence on tetrahydrocannabinol in rhesus monkeys. J Pharmacol Exp Ther (1986) 1.02
A cannabinoid with cardiovascular activity but no overt behavioral effects. Experientia (1977) 1.00
Etorphines: mu-opioid receptor-selective antinociception and low physical dependence capacity. Eur J Pharmacol (1997) 1.00
Self-administration of methylenedioxymethamphetamine (MDMA) by rhesus monkeys. Drug Alcohol Depend (1986) 0.99
Effects of cannabinoids on host resistance to Listeria monocytogenes and herpes simplex virus. Infect Immun (1979) 0.99
Postcyclodialysis hypotony. Am J Ophthalmol (1969) 0.98
Relationship of brain morphine levels to analgesic activity in acutely treated mice and rats and in pellet implanted mice. J Pharmacol Exp Ther (1975) 0.98
Surgical landmarks in trabecular surgery. Am J Ophthalmol (1975) 0.97
Endothelial cell loss from intraocular lens insertion. Ophthalmology (1978) 0.97
Tonometric calibration for the rabbit eye. Arch Ophthalmol (1970) 0.96
Naloxone-precipitated jumping activity in mice following the acute administration of morphine. Eur J Pharmacol (1974) 0.96
Time analysis of corneal endothelial cell density after cataract extraction. Am J Ophthalmol (1979) 0.96
Very long-acting narcotic antagonists: the 14 beta-p-substituted cinnamoylaminomorphinones and their partial mu agonist codeinone relatives. Arzneimittelforschung (1989) 0.95
Peripherally inserted central catheters: experience in 523 children. Radiology (1997) 0.94
Susceptibility of Naegleria fowleri to delta 9-tetrahydrocannabinol. Antimicrob Agents Chemother (1979) 0.94
Vasoconstrictor actions of delta8- and delta9-tetrahydrocannabinol in the rat. J Pharmacol Exp Ther (1976) 0.94
Conservative treatment of intraocular melanomas. Trans Am Acad Ophthalmol Otolaryngol (1971) 0.93
Fluorescein angiography during induced ocular hypertension in glaucoma. Br J Ophthalmol (1972) 0.92
Prevention of writhing and other effects of narcotics and narcotic antagonists in mice. J Pharmacol Exp Ther (1968) 0.90
Discriminative stimulus and neurochemical mechanism of cathinone: a preliminary study. NIDA Res Monogr (1979) 0.90
Some pharmacological and toxicological effects of 1-trans- 8 and 1-trans- 9 -tetrahydrocannabinol in laboratory rodents. Arch Int Pharmacodyn Ther (1972) 0.90
Cycloplegic provocative testing. Arch Ophthalmol (1969) 0.89
Concomitant blowout fracture of the orbit and rupture of the globe. Arch Ophthalmol (1970) 0.89
Intraocular pressure rebound. Br J Ophthalmol (1971) 0.89
Semiautomated suction ophthalmodynamometry. Am J Ophthalmol (1969) 0.89
Radiologic removal of buried gastrostomy bumpers in pediatric patients. AJR Am J Roentgenol (2001) 0.89
Synthesis and in vitro and in vivo activity of (-)-(1R,5R,9R)- and (+)-(1S,5S,9S)-N-alkenyl-, -N-alkynyl-, and -N-cyanoalkyl-5, 9-dimethyl-2'-hydroxy-6,7-benzomorphan homologues. J Med Chem (2000) 0.88
Origin of the peripapillary vascular network. Am J Ophthalmol (1970) 0.88
Effects of the specific α4β2 nAChR antagonist, 2-fluoro-3-(4-nitrophenyl) deschloroepibatidine, on nicotine reward-related behaviors in rats and mice. Psychopharmacology (Berl) (2012) 0.88
Distribution of radioactivity in brain of tolerant and nontolerant pigeons treated with 3 H- 9 -tetrahydrocannabinol. Biochem Pharmacol (1973) 0.88
Antipyretic, analgesic and anti-inflammatory effects of delta 9-tetrahydrocannabinol in the rat. Eur J Pharmacol (1973) 0.87
Experimental study of cartilage setons. Br J Ophthalmol (1970) 0.87
Stereoisomers of [3H]-N-allylnormetazocine bind to different sites in mouse brain. J Pharmacol Exp Ther (1984) 0.87
Hospitalization and cataract surgery. Ann Ophthalmol (1981) 0.87
The effects of chronic administration of trans- 9 -tetrahydrocannabinol on behavior and the cardiovascular system of dogs. Arch Int Pharmacodyn Ther (1972) 0.87
Antitussive effect of the optical isomers of mu, kappa and sigma opiate agonists/antagonists in the cat. J Pharmacol Exp Ther (1983) 0.86
Cycloplegic provocative testing after topical administration of steroids. Arch Ophthalmol (1971) 0.86
The effect of 1-trans-delta 9-tetrahydrocannabinol on the hypothalamo-hypophyseal-adrenal axis of rats. Eur J Pharmacol (1970) 0.86
Oculo-cerebro-renal syndrome. Report of a case in a baby girl. Br J Ophthalmol (1970) 0.86
Dependence studies on new compounds in the rhesus monkey, rat and mouse (1989). NIDA Res Monogr (1989) 0.86
Sensitivity of human conjunctival tissue cultures to adenovirus 8, herpes simplex and vaccinia viruses. Induction of resistance by an interferon inducer. Proc Soc Exp Biol Med (1973) 0.86
Longterm timolol therapy. Surv Ophthalmol (1979) 0.86
Parasympatholytic (anticholinergic) esters of the isomeric 2-tropanols. 1. Glycolates. J Med Chem (1977) 0.85
Dependence studies of new compounds in the rhesus monkey, rat, and mouse (1985). NIDA Res Monogr (1986) 0.85
Tissue culture methods for testing the toxicity of ocular plastic materials. Am J Ophthalmol (1975) 0.85
Abdominal injuries in automobile accidents: review of care of fatally injured patients. J Trauma (1977) 0.85
Acetazolamide and outflow facility. Arch Ophthalmol (1966) 0.85
Prone provocative testing for narrow angle glaucoma. Arch Ophthalmol (1972) 0.85
The effect of morphine, nalorphine, naloxone, pentazocine, cyclazocine and oxotremorine on the synthesis and release of acetylcholine by mouse cerebral cortex slices in vitro. Arch Int Pharmacodyn Ther (1970) 0.84
How does a filtering bleb work? Trans Am Acad Ophthalmol Otolaryngol (1966) 0.84
Comparative studies of the pharmacological effects of the d- and l-isomers of codeine. J Pharmacol Exp Ther (1980) 0.84
Concomitant medial wall fracture and blowout fracture of the orbit. Arch Ophthalmol (1971) 0.84
N-Cyclohexylethyl-N-noroxymorphindole: a mu-opioid preferring analogue of naltrindole. Bioorg Med Chem Lett (2000) 0.84
Evaluation of the discriminative stimulus and reinforcing effects of gammahydroxybutyrate (GHB). Psychopharmacology (Berl) (1996) 0.84
3-Alkyl ethers of clocinnamox: delayed long-term mu-antagonists with variable mu efficacy. J Med Chem (1998) 0.84
Enhanced susceptibility of mice to combinations of delta 9-tetrahydrocannabinol and live or killed gram-negative bacteria. Infect Immun (1977) 0.83
Behavioral comparisons of the stereoisomers of tetrahydrocannabinols. Life Sci (1981) 0.83
Response of retinal ganglion cell axons to lesions in the adult mouse retina. Invest Ophthalmol (1973) 0.83
Discriminative stimulus properties of the optical isomers of nicotine. Psychopharmacology (Berl) (1980) 0.83
Cataract extraction in glaucoma. Am J Ophthalmol (1979) 0.83
Immunological aspects of intraocular lenses. Int Ophthalmol Clin (1982) 0.83
Fluorescein iris angiography in the albino rabbit. Arch Ophthalmol (1972) 0.83